Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

326
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
326
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

930
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
930
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

58
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
58
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.7K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

148
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
148
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

2.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extract of Agathis dammara and its active monomer araucarone attenuate metabolic dysfunction-associated steatotic liver disease by targeting carboxylesterase 2.

Journal of ethnopharmacology·2026
Same author

Cycloastragalol nanoparticle-loaded composite hydrogel as an injectable embolic agent for vascular repair in a mouse model of abdominal aortic aneurysm.

Journal of nanobiotechnology·2026
Same author

Activating the cellular scavenger: A bioactive hydrogel promotes diabetic wounds via plant exosome-like nanovesicles enhanced macrophage efferocytosis.

Bioactive materials·2026
Same author

Non-enzymatic function of QSOX2 directly regulates the JUNB-ITGB4 axis and enhanced resistance to osimertinib in EGFR-mutation lung adenocarcinoma.

Cell death discovery·2026
Same author

Point-of-Care Detection of Dual Methylation Genes for Rapid Bladder Cancer Diagnosis and Prognosis.

Analytical chemistry·2026
Same author

Long-term social isolation during adolescence exacerbated cardiac dysfunction after myocardial infarction.

Translational psychiatry·2026
Same journal

Direct Transport to a Comprehensive Stroke Center May Offer Outcome Benefits in Metropolitan Thrombectomy Networks.

Journal of stroke·2026
Same journal

A Decade of Transformation in Stroke Care in South Korea (2013-2023): Increasing Ambulance Use but Persistent Prehospital Delay and Reversing Mortality Trends.

Journal of stroke·2026
Same journal

Divergent Small Vessel Disease Burden in Warfarin-Associated and Direct Oral Anticoagulant-Associated Intracerebral Hemorrhage.

Journal of stroke·2026
Same journal

Impact of Low-Density Lipoprotein Cholesterol Levels on Atherosclerotic Vascular Changes: Analysis of Korean Treat Stroke to Target Trial.

Journal of stroke·2026
Same journal

Cortical Microinfarcts Are Related to Amyloid Pathology and Cognitive Decline in Spontaneous Intracerebral Hemorrhage.

Journal of stroke·2026
Same journal

Safety of Endovascular Thrombectomy in Isolated Cervical Internal Carotid Artery Occlusion While on Oral Anticoagulation.

Journal of stroke·2026
See all related articles

Related Experiment Video

Updated: Oct 4, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.0K

Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke?

Hai-Jie Liang1,2, Qing-Yi Zhang1,2,3,4,5, Yi-Tong Hu1,2

  • 1Department of Pharmacology, School of Basic Medical Sciences, Beijing, China.

Journal of Stroke
|February 8, 2022
PubMed
Summary
This summary is machine-generated.

High triglyceride levels (hypertriglyceridemia) may increase ischemic stroke risk by affecting blood vessels and viscosity. Further research is needed to understand its role in stroke development and outcomes.

Keywords:
HypertriglyceridemiaIncidenceIschemic strokePrognosis

More Related Videos

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.2K
A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

570

Related Experiment Videos

Last Updated: Oct 4, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.0K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.2K
A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

570

Area of Science:

  • Biochemistry
  • Neurology
  • Cardiovascular Medicine

Background:

  • Hypertriglyceridemia involves defects in triglyceride metabolism, leading to elevated plasma triglyceride levels.
  • While less studied than cholesterol, plasma triglycerides, particularly nonfasting levels, are linked to ischemic stroke risk.
  • Potential mechanisms include promoting atherosclerosis, thrombosis, and increased blood viscosity.

Purpose of the Study:

  • To explore the association between hypertriglyceridemia and ischemic stroke.
  • To investigate the potential dual role of hypertriglyceridemia in stroke risk and prognosis.

Main Methods:

  • Review of existing literature on hypertriglyceridemia and stroke.
  • Analysis of epidemiological data correlating triglyceride levels with stroke incidence.
  • Exploration of pathophysiological mechanisms linking hypertriglyceridemia to atherosclerosis and thrombosis.

Main Results:

  • Plasma triglycerides, especially nonfasting, show a correlation with ischemic stroke risk.
  • Hypertriglyceridemia may contribute to stroke through atherosclerosis and thrombosis.
  • Emerging evidence suggests potential protective effects in post-stroke patients, though mechanisms are unclear.

Conclusions:

  • Hypertriglyceridemia is a significant factor to consider in ischemic stroke risk assessment.
  • Further research is crucial to fully understand the complex role of hypertriglyceridemia in stroke etiology and patient outcomes.